| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $133.6M | -35.5% |
| R&D Expense | $210.4M | +11.1% |
| SG&A Expense | $61.0M | +10.9% |
| Operating Income | -$137.8M | -268.9% |
| Income Tax | $3.3M | — |
| Net Income | -$133.3M | -267.0% |
| EPS (Basic) | -$1.62 | -260.0% |
| EPS (Diluted) | -$1.62 | -260.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $154.3M | -53.1% |
| Short-term Investments | $558.5M | +37.5% |
| Current Assets | $726.4M | -3.1% |
| Total Assets | $787.6M | -3.3% |
| Current Liabilities | $93.8M | -32.8% |
| Total Liabilities | $573.2M | +11.5% |
| Stockholders' Equity | $214.4M | -28.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.3M | -106.8% |
| Capital Expenditures | $4.1M | +26.8% |
| Investing Cash Flow | -$159.0M | -220.2% |
| Financing Cash Flow | $4.5M | -85.1% |
| Free Cash Flow | -$24.4M | -108.3% |